Tools

Hepatitis Commodities Access in Resource-Limited Settings

This tool is a mapping of hepatitis procurement processes for prevention tools, diagnostics, monitoring and treatment, the aim is to increase awareness and information on cost and procurement within the hepatitis community, in order to increase access to viral hepatitis medicines and technologies in low-and-middle income countries, including HBV birth-dose vaccine, HBV treatment and HCV cure uptake.

HBV Research Protocols

There is an urgent need for centralized repositories of HBV-related materials that are readily accessible to HBV researchers globally. Critical to this will be quality assurance of the samples, and the availability of matching clinical data. This repository of HBV-related research protocols is designed to facilitate studies and the development of new drugs.

HBV Cure FAQs: All you need to know to understand HBV cure research

For the past few years HBV Cure Webinars for community have been taking place, aimed at empowering the community by equipping them with the knowledge needed to understand HBV cure research. Now an international consortium of organizations, coordinated by ICE-HBV, have come together to create an enduring tool for the community to understand cure research. This tool, the HBV Cure FAQs, will be a collection of short videos that answer key questions relating to HBV cure research.

GCHE/ICE-HBV HDV Webinars

ICE-HBV and The Coalition for Global Hepatitis Elimination hosted a webinar on July 18th, 2024 to review the latest guidance, data, and testing and treatment context for hepatitis D (HDV). This webinar highlighted implications from the recently updated World Health Organization HBV guidelines for HDV management. Speakers presented the HDV testing landscape, the status of screening policies, current treatment options, and challenges of treatment accessibility. This webinar is the third collaboration between ICE-HBV and the Coalition with the aim to bring awareness to the global burden of HDV and the needed research, policy, and implementation to expand access to HDV care.
 

Agenda:
Welcome and Introductions | Chairs: Maura Dandri, University Medical Center Hamburg-Eppendorf, Germany; Massimo Levrero, University Claude Bernard Lyon 1, France; John Ward, Coalition for Global Hepatitis Elimination


Presentation 1 | HDV global burden and care cascade: the WHO perspective | Niklas Luhmann, World Health Organization


Presentation 2 | Challenges in HDV diagnosis | Elisabetta Degasperi, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Italy


Presentation 3 | The evolving landscape of HDV / CHD treatment: from discovery to access to care | Heiner Wedemeyer, Hanover Medical School, Germany


Roundtable discussion with the contributions of:

  • Naranjargal Dashdorj, Onom Foundation, Mongolia
  • Pietro Lampertico, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico and University of Milan, Italy
  • Richard Njouom, Centre Pasteur of Cameroon, Institut Pasteur, Cameroon
  • Fabien Zoulim, University of Lyon, France 

The recording of the webinar can be watched here: Full Webinar Recording | 2024 Update on CHD: from Disease Awareness to Therapeutic Opportunities